Article

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in severe acute respiratory syndrome corona virus 2 infection/COVID 19

2020-12-22

Abstract excerpt

<title>Abstract</title> <p>Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infections (COVID 19) is a progressive viral infection that has been investigated extensively. However, genetic features and molecular pathogenesis underlying SARS-CoV-2 infection remain unclear. Here we used bioinformatics to investigate the candidate genes associated in the molecular pathogenesis of SARS-CoV-2 infection. Ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6b2ac911-e247-5855-8085-65748ba60832
DOI: 10.21203/rs.3.rs-133291/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in severe acute respiratory syndrome corona virus 2 infection/COVID 19DOI 10.21203/rs.3.rs-133291/v1Read

Bioinformatics analysis of expression profiling by high throughput sequencing for identification of potential key genes among SARS-CoV-2/COVID 19Semantic proximity Read

Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs RepurposingSemantic proximity Read

In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposingSemantic proximity Read

Screening key genes and signaling pathways in COVID-19 infection and its associated complications by integrated bioinformatics analysisSemantic proximity Read

Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methodsSemantic proximity Read

Integrated bioinformatics analysis to determine the impact of SARS-CoV-2 infections to Heart Failure patientsSemantic proximity Read

Depicting the innate immune response landscape in Covid-19 emphasized type 1 interferon a key defense against SARS-CoV-2Semantic proximity Read

Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approachesSemantic proximity Read

Identification of potential biomarkers and inhibitors for SARS-CoV-2 infectionSemantic proximity Read

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read

Transcriptome and SARS-CoV-2 biological network directed analysis for better therapeutic developmentSemantic proximity Read

Identification of hub genes and molecular subtypes in COVID-19 based on WGCNA.Semantic proximity Read